Patients with unresectable liver metastases (LM) from colorectal cancer (CRC)have a poor prognosis. In patients with resectable disease, surgery offers a distinct survival benefit. This study will off
Interventions: Experimental group:CAR-T immune cell therapy Primary outcome(s): Successful expansion of CAR-T cells;Objective response rate Study Design: Single arm
RATIONALE: Learning about quality of life, symptoms, and health behaviors in colorectal cancer survivors may help to determine the long-term effects of colon and rectal cancer treatments and may help
